Cardio-TriTest vs VX1
AI Verdict
Choose Cardio-TriTest if…
Choose Cardio-TriTest if your primary care or general cardiology clinic requires a comprehensive, non-invasive diagnostic tool for early and broad cardiovascular disease detection. This device is ideal for synchronizing and visually correlating multiple heart bio-signals (ECG, PCG, MCG) to enhance diagnostic accuracy in a clinical setting.
View Cardio-TriTest →Choose VX1 if…
Choose VX1 if your electrophysiology lab needs real-time AI assistance during atrial fibrillation and atrial tachycardia ablation procedures. This software is specifically designed to help cardiac electrophysiologists identify dispersed electrograms, aiming to standardize outcomes and reduce variability during complex interventional procedures.
View VX1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cardio-TriTest | VX1 |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | On-premise (device) | Software integrated with existing electrophysiology (EP) lab mapping and recording systems. |
| FDA Status | Unknown | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cardio-TriTestCardio-TriTest is designed for primary care, offering a non-invasive, 3-in-1 test with a visually correlated output for general practitioners, indicating a broader and simpler usability profile. While VX1 is described as user-friendly within its niche, it operates in the highly specialized and complex environment of cardiac ablation procedures, requiring integration into existing EP lab systems.
Clinical Value
VX1Both tools have strong clinical value and FDA clearance. However, VX1 directly impacts the efficacy and standardization of complex interventional procedures for atrial fibrillation by providing real-time AI guidance to reduce operator variability and improve outcomes. Cardio-TriTest offers valuable early detection in primary care, but VX1's impact on a high-stakes, specialized treatment procedure appears more transformative for patient outcomes in its specific niche.
Pricing & Value
TieBoth tools require direct contact for pricing, making a direct cost comparison impossible. While both offer significant value propositionsu2014Tool A through early detection and reduced unnecessary referrals, and Tool B through improved procedural outcomes and reduced re-interventionsu2014without transparent pricing, it is not possible to definitively determine which offers superior financial value.
Enterprise Readiness
VX1VX1 demonstrates strong enterprise readiness through its seamless integration with most existing EP lab mapping and recording systems, which is crucial for adoption in complex hospital environments. While Cardio-TriTest is HIPAA compliant and device-based for primary care, VX1's compatibility with diverse EP equipment makes it highly adaptable for specialized hospital networks.
Innovation
VX1VX1 represents a more groundbreaking application of AI by providing real-time, AI-guided assistance during complex interventional cardiac ablation procedures, directly impacting surgical precision and outcomes. While Cardio-TriTest's multi-modal diagnostic approach for primary care is innovative, VX1's in-procedure AI guidance for identifying specific electrogram abnormalities is a more novel and direct application of AI in a high-stakes clinical setting.
Support & Docs
VX1Volta Medical provides clear access to essential support documentation, including Instructions For Use and User Manuals, directly on their website, along with extensive clinical evidence and references. In contrast, specific support and documentation details for Cardio-TriTest were not readily available through web searches.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cardio-TriTest | VX1 |
|---|---|---|
| Tool Name | Cardio-TriTest | VX1 |
| Company | Cardio-Phoenix Inc. | Volta Medical |
| Description/Purpose | AI-powered 3-in-1 diagnostic device combining ECG, PCG, and MCG for earlier and more comprehensive cardiovascular disease detection in primary care. | FDA-cleared AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. |
| Key Diagnostic/Assistance Method | 3-in-1 diagnostic device (ECG, PCG, MCG) with AI-powered analysis for heart disease detection and visual correlation of heart bio-signals. | AI-guided real-time identification of dispersed electrograms (EGMs) during ablation procedures, analyzing 3D anatomical and electrical maps. |
| Targeted Condition/Procedure | Earlier and more comprehensive cardiovascular disease detection. | Assists cardiologists during AFib and atrial tachycardia ablation procedures. |
| Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring Cardio-TriTest and VX1.